Overview:
“Our 8th Annual Access to Innovation conference is a full day event that brings together life sciences leaders from academia, research, health institutions, government, and industry to discuss emerging trends, innovation, economic impact, translational science, and policies to advance the sector. This year’s event will resume in person.”
Agenda:
- Guest Arrival: 8:00am PT
- Programming: 8:30am-6:30pm PT
- Networking Reception: 6:30pm-8:00pm PT
- Buffet lunch and light reception refreshments will be provided.
Confirmed Session Themes:
- Licensing and Collaboration Agreements in the Life Sciences Sector
- Immuno-engineering: From Genomics to Therapeutics
- A Vision for Clinical Trials in British Columbia
- Evolving Access to Innovation in Precision Medicine
- Navigating Government Support for SME IP Strategies
Confirmed Speakers:
- Paul Armitage, Partner, Gowling WLG
- Dr. Julia Bickford, Regional Director, Research Evaluation and Analytics, Northern Health
- Dr. Michael Chen, Clinical Pathologist, Department of Laboratory Medicine, Island Health; Adjunct Assistant Professor, University of British Columbia & University of Victoria
- Abi Coman-Walker, COO, Acuitas Therapeutics
- Stephen Filbey, Founder & Principal Consultant, WestPAR Consultancy
- Dr. David Goodlett, Professor, University of Victoria; Director, University of Victoria-Genome BC Proteomics Centre
- Dr. Fraser Hof, AVP Research, University of Victoria
- Dr. Shirin Kalyan, VP, Scientific Innovation, Qu Biologics
- Dr. Barb Kinnaird, CEO, Response Biomedical
- Dr. Véronique Lecault, COO, AbCellera
- Jennifer Marles, Partner, Oyen Wiggs
- Dr. Robert McMaster, Vice Dean, Research & Professor, Department of Medical Genetics, University of British Columbia
- Dr. Nathan Michaels, Director, Precision Medicine and Genetic Services, Ministry of Health
- Alison Orth, Director, Clinical Trials BC, Michael Smith Health Research BC
- Dr. Federica di Palma, CSO & VP, Research and Innovation, Genome BC
- Eric Petersson, Trade Commissioner, Pacific Regional Office, Global Affairs Canada
- Darcia Pope, Chief Transformation Officer & Vice President, Innovation & Planetary Health, Vancouver Coastal Health
- Andrea Sambati, President and CEO, Boehringer Ingelheim Canada
- Angie Schick, Executive Director, New Ventures BC
- Helen Sheridan, Chief Human Resources Officer, STEMCELL Technologies
- Dr. Cynthia Shippam, Industry Technology Advisor, National Research Council Canada – IRAP
- Dr. Gavin Stuart, Professor, Department Obstetrics and Gynecology, UBC
- James Taylor, General Manager, Genomics Medicine, Cytiva
- Dr. Bryan Tennant, Scientific Director, Medical Affairs – Vaccines, GSK
- Laura Walsh, Senior Vice President, Philanthropy, VGH & UBC Hospital Foundation
- Dr. Stephen Yip, Neuropathologist, Vancouver General Hospital; Medical Director of CGL/CCG, BC Cancer